Intestinal Carcinoid and Pancreatic Neuroendocrine Tumor Cell Lines Needed
The lack of well-validated and widely accepted cell lines derived from intestinal carcinoid and pancreatic neuroendocrine tumors (PNET) is a significant barrier for research and development of new therapies.